Inventaire - your friends and communities are your best library

Epac1 promotes melanoma metastasis via modification of heparan sulfate.

author

Masanari Umemura

published in: Pigment Cell & Melanoma Research

date of publication: 2011-05-13

Cites articles 28

Date

Title

Authors

2010-06-15

Exchange protein directly activated by cyclic AMP increases melanoma cell migration by a Ca2+-dependent mechanism
2009-08-05

Epac increases melanoma cell migration by a heparan sulfate-related mechanism
2009-11-17

Epac inhibits migration and proliferation of human prostate carcinoma cells

Herbert Rübben
2009-01-27

Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro
2009-04-27

Peripheral mural cell recruitment requires cell-autonomous heparan sulfate

Holger Gerhardt
2009-12-01

Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificities

David G. Fernig, Paul D Losty
2008-12-06

Fibroblast growth factor-2 modulates melanoma adhesion and migration through a syndecan-4-dependent mechanism

Dragana Nikitovic, Nikos K. Karamanos
2007-02-01

Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development

Holger Gerhardt, Lena Kjellén, Christer Betsholtz, Ulf Landegren, Ulf Lindahl, Göran Bondjers
2007-06-01

Melanoma invasion - current knowledge and future directions

Cédric Gaggioli, Erik Sahai
2007-12-03

Requirements for sulfate transport and the diastrophic dysplasia sulfate transporter in fibronectin matrix assembly
2007-09-05

Dopamine induces apoptosis in young, but not in neonatal, neurons via Ca2+-dependent signal

Susumu Minamisawa
2007-12-12

Bud specific N-sulfation of heparan sulfate regulates Shp2-dependent FGF signaling during lacrimal gland induction

Jeffrey Esko
2007-10-01

AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts

Serk In Park
2006-05-01

The current epidemiology of cutaneous malignant melanoma
2006-11-02

Epac proteins: multi-purpose cAMP targets
2005-04-01

Lack of clinical efficacy of imatinib in metastatic melanoma

Paul La Rosée, Andreas Hochhaus
2004-04-01

Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate

Christer Betsholtz
2004-07-15

Direct inhibition of type 5 adenylyl cyclase prevents myocardial apoptosis without functional deterioration
2003-11-13

Among circulating hematopoietic cells, B-CLL uniquely expresses functional EPAC1, but EPAC1-mediated Rap1 activation does not account for PDE4 inhibitor-induced apoptosis

Sanjay Tiwari, Kyriacos N Felekkis, David Sherr, Adam Lerner
2002-12-01

Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function

Ulf Lindahl, Lena Claesson-Welsh
2002-01-01

A growing family of guanine nucleotide exchange factors is responsible for activation of Ras-family GTPases

John F Rebhun
2000-09

Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization

Robert J. Linhardt, Joseph Schlessinger
1999-01-29

Molecular cloning and expression of a third member of the heparan sulfate/heparin GlcNAc N-deacetylase/ N-sulfotransferase family
1999-11-01

Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes
1998-12-01

Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP

Robbert H Cool
1998-10-01

Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo

John Whitelock
1996-02-23

Heparin structure and interactions with basic fibroblast growth factor

Robert J. Linhardt
1991-01-01

Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line

Article - wd:Q39549002

Welcome to Inventaire

the library of your friends and communities

learn more